2016newlogowords
AACT/ABAT Journal Club #14: The Truth, the Whole Truth, and a Return to the Primary Literature Enduring Material
Mr pencil

How would you like your name to appear on your certificate?



Agreement
By completing this form, you attest that you have attended the activity in its entirety.
Was the educational content of value to you?
Was the educational content scientifically sound?
If no, please explain...
Did you perceive any commercial bias or influence in the educational content?
If yes, please explain...
Did this activity improve your Skills or Strategy?
If yes, how...
Do you think what you learned will benefit you in your practice?
If yes, how...
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything
What questions are you having in your practice that you would like to see addressed in an educational activity?
PHARMACISTS: If you do not provide your NABP ID AND your DATE OF BIRTH, your hours will not be uploaded to CPE Monitor.
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924: 
Please rate Regan Baum
Content/Teaching Methods
Presentation/Handouts
Relevance of Content to Objectives
Independence, Objectivity, Balance, Scientific Rigor
Please rate Nena J. Bowman
Content/Teaching Methods
Presentation/Handouts
Relevance of Content to Objectives
Independence, Objectivity, Balance, Scientific Rigor
Were the learning objectives met?
Describe the background evidence and mechanism of QTC prolongation with ondansetron 
Describe the clinical implications and patients most at risk for this prolongation
Describe the theorized mechanism of toxicity when patients combine metronidazole and ethanol
Identify the acetaldehyde levels measured in blood after human volunteers ingested metronidazole and ethanol
Recognize clinically significant changes in heart rate, blood pressure, and facial temperature in patients when metronidazole and ethanol are co-ingested
When you viewed this webinar, were you in a group or by yourself?
If in a group, with how many people?
Comments:
Mr question